Resources
Recent Publications by CTL

Recent Publications by CTL

CTL prides itself of an active, in-house ELISPOT/FluoroSpot-oriented research effort that aims to further this technology’s readiness for the immune monitoring community. Meet our scientists and learn what motivates them. Here are their latest contributions:

Sebastian Köppert, Carla Wolf, Noémi Becza, Giuseppe A. Sautto, Fridolin Franke, Stefanie Kürten, Ted M. Ross, Paul V. Lehmann, and Greg A. Kirchenbaum.

Affinity tag coating enables reliable detection of antigen-specific B cells in ImmunoSpot Assays.
Cells, 2021,10:1843
Alexander A. Lehmann, Greg A Kirchenbaum, Ting Zhang, Pedro A Reche, Paul V Lehmann.

Deconvoluting the T cell response to SARS-CoV-2: specificity versus chance- and cognate cross-reactivity.
2021. Frontiers in Immunology. 2021, 12: 982
Alexander A. Lehmann, Pedro A. Reche, Ting Zhang, Maneewan Suwansaard, and Paul. V. Lehmann.

CERI, CEF-X, and CPI: largely improved positive controls for testing antigen-specific T cell function in PBMC compared to CEF.
Cells, 2021, 10, 248.
Alexander A. Lehmann, Ting Zhang, Pedro A Reche, Paul V Lehmann.

Discordance between the predicted vs. the actually recognized CD8+ T cell epitopes of HCMV pp65 antigen and aleatory epitope dominance.
Frontiers in Immunology, 2021, 11: 618428
Anna Przybyla, Alexander A. Lehmann, Ting Zhang, Jacek Mackiewicz, Łukasz Galus, Greg A. Kirchenbaum, Andrzej Mackiewicz, Paul V. Lehmann.

Functional T cell reactivity to melanocyte antigens is lost during development of malignant melanoma, but is restored with successful immunotherapy.
2021 Cancers,13: 223
Alexander Lehmann and Paul. V. Lehmann.

Aleatory epitope recognition prevails in human T cell responses?
Critical Reviews in Immunology, 2020, 40: 225-235.
Fridolin Franke, Greg A. Kirchenbaum, Stefanie Kuerten, and Paul V. Lehmann.

IL-21 in conjunction with anti-CD40 and IL-4 constitutes a potent polyclonal B cell stimulator for monitoring antigen-specific memory B cells.
Cells, 2020, 9, 433.

Search all of our 217 ELISPOT/FluoroSpot-related publications by topic.

See CV of our lead scientist, Prof. Paul V. Lehmann

Essential

Marketing

Google Analytics

Recent Publications by CTL

CTL prides itself of an active, in-house ELISPOT/FluoroSpot-oriented research effort that aims to further this technology’s readiness for the immune monitoring community. Meet our scientists and learn what motivates them. Here are their latest contributions:

Search all of our 217 ELISPOT/FluoroSpot-related publications by topic.

See CV of our lead scientist, Prof. Paul V. Lehmann